Icad inc. (NASDAQ:ICAD) posted its quarterly earnings data on Wednesday. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.05.
Icad inc. (NASDAQ:ICAD) traded up 2.61% during mid-day trading on Wednesday, reaching $4.71. 43,719 shares of the company were exchanged. Icad inc. has a one year low of $2.95 and a one year high of $6.23. The stock has a 50-day moving average price of $5.04 and a 200 day moving average price of $4.85. The company’s market capitalization is $74.87 million.
iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).
